Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000020 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 17, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
21,000
Total Value
$277,798.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 37,518 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 41,018 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Sale | 6,064 | $32.30 | $195,872.66 | 34,954 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 17, 2026 | Sale | 936 | $32.78 | $30,686.01 | 34,018 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Feb 17, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 218,063 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Feb 17, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 189,492 | Direct | โ | View Details |